BRIEF—Seqirus appoints new general manager

Australia’s CSL has appointed Anjana Narain to lead its UK-based influenza vaccine business, Seqirus. She will replace Gordon Naylor, who is retiring.

Anjana Narain has 27 years of experience with major pharmaceutical companies such as GlaxoSmithKline, Merck & Co, and Bayer.

For nine years, she led major businesses at GSK including global influenza commercialization, US respiratory biologics and general management of vaccines, primary care and HIV.